The Valley Desk

NCT01356498 · Interventional trial

Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout

Overall registry status Completed

Phase 3

Conditions Gout

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov